# Menopausal HT for Women Living With HIV (HoT)

> **NCT06856174** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 105 (estimated)

## Conditions studied

- HIV Infection
- Menopause

## Interventions

- **DRUG:** Transdermal estradiol gel
- **DRUG:** Micronized Progesterone
- **DRUG:** Placebo for estradiol gel
- **DRUG:** Placebo for micronized progesterone

## Key facts

- **NCT ID:** NCT06856174
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2027-09-20
- **Final completion:** 2027-09-20
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06856174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06856174, "Menopausal HT for Women Living With HIV (HoT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06856174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*